Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis

References

• Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ . The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American association for the study of liver diseases, American college of gastroenterology, and the American gastroenterological association. Hepatology. 2012;55:1–20. doi:10.1002/hep.25762.
   Web of Science ®Google Scholar
• Younossi ZM, Rinella ME, Sanyal AJ, Harrison SA, Brunt EM, Goodman Z, Cohen DE, Loomba R. From NAFLD to MAFLD: implications of a Premature Change in Terminology. 2021;73(3):1194–1198. doi:10.1002/hep.31420.
   Google Scholar
• Taylor RS, Taylor RJ, Bayliss S, Hagström H, Nasr P, Schattenberg JM, Ishigami M, Toyoda H, Wai-Sun Wong V, Peleg N, et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology. 2020;158(6):1611–25.e12. doi:10.1053/j.gastro.2020.01.043.
   PubMed Web of Science ®Google Scholar
• Rinella ME, Sanyal AJ. Management of NAFLD: a stage-based approach. Nat Rev Gastroenterol Hepatol. 2016;13(4):196–205. doi:10.1038/nrgastro.2016.3.
   PubMed Web of Science ®Google Scholar
• Lambert JE, Ramos–Roman MA, Browning JD, Parks EJ. Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2014;146(3):726–735. doi:10.1053/j.gastro.2013.11.049.
   PubMed Web of Science ®Google Scholar
• Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A. Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: implications in Nonalcoholic Fatty Liver Disease. Gastroenterology. 2020;158(7):1899–1912. doi:10.1053/j.gastro.2019.12.054.
   PubMed Web of Science ®Google Scholar
• Mansbach, Siddiqi S, Charles M, Siddiqi S, Siddiqi S. Control of chylomicron export from the intestine. Am J Physiol Gastrointest Liver Physiol. 2016;310(9):G659–G68. doi:10.1152/ajpgi.00228.2015.
   PubMed Web of Science ®Google Scholar
• Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115(5):1343–1351. doi:10.1172/JCI23621.
   PubMed Web of Science ®Google Scholar
• Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, Okunade AL, Patterson BW, Nyangau E, Field T, et al. Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease. J Clin Invest. 2020;130(3):1453–1460. doi:10.1172/JCI134165.
   PubMed Web of Science ®Google Scholar
• Byrne CD, Targher G. What’s new in NAFLD pathogenesis, biomarkers and treatment? Nat Rev Gastroenterol Hepatol. 2020;17(2):70–71. doi:10.1038/s41575-019-0239-2.
   PubMed Web of Science ®Google Scholar
• Lee G, You HJ, Bajaj JS, Joo SK, Yu J, Park S, Kang H, Park JH, Kim JH, Lee DH, et al. Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD. Nat Commun. 2020;11(1):4982. doi:10.1038/s41467-020-18754-5.
   PubMed Web of Science ®Google Scholar
• Aron-Wisnewsky J, Vigliotti C, Witjes J, Le P, Holleboom AG, Verheij J, Nieuwdorp M, Clément K. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat Rev Gastroenterol Hepatol. 2020;17(5):279–297. doi:10.1038/s41575-020-0269-9.
   PubMed Web of Science ®Google Scholar
• Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018;361:k2179. doi:10.1136/bmj.k2179.
   PubMedGoogle Scholar
• Luukkonen PK, Dufour S, Lyu K, Zhang X-M, Hakkarainen A, Lehtimäki TE, Cline GW, Peterson KF, Shulman GI, Yki-Järvinen H . Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease. 2020; 117:7347–7354 doi:10.1073/pnas.1922344117.
   Google Scholar
• Mardinoglu A, Wu H, Bjornson E, Zhang C, Hakkarainen A, Räsänen SM, Lee S, Mancina RM, Bergentall M, Pietiläinen KH, et al. An integrated understanding of the rapid metabolic benefits of a carbohydrate-restricted diet on hepatic steatosis in humans. Cell Metab. 2018;27(3):559–71.e5. doi:10.1016/j.cmet.2018.01.005.
   PubMed Web of Science ®Google Scholar
• Benítez-Páez A, Kjølbæk L, Gómez Del Pulgar EM, Brahe LK, Astrup A, Matysik S, Schött H-F, Krautbauer S, Liebisch G, Boberska J, et al. A multi-omics approach to unraveling the microbiome-mediated effects of arabinoxylan oligosaccharides in overweight humans. mSystems. 2019;4(4):e00209–19. doi:10.1128/mSystems.00209-19.
   PubMed Web of Science ®Google Scholar
• Anderson JW, Zeigler JA, Deakins DA, Floore TL, Dillon DW, Wood CL, Oeltgen PR, Whitley RJ . Metabolic effects of high-carbohydrate, high-fiber diets for insulin-dependent diabetic individuals. Am J Clin Nutr. 1991;54(5):936–943. doi:10.1093/ajcn/54.5.936.
   PubMed Web of Science ®Google Scholar
• Kwon OW, Jun DW, Lee SM, Lee KN, Lee HL, Lee OY, Yoon BC, Choi HS . Carbohydrate but not fat is associated with elevated aminotransferases. Aliment Pharmacol Ther. 2012;35:1064–1072 doi:10.1111/j.1365-2036.2012.05061.x.
   PubMed Web of Science ®Google Scholar
• Mallick H, Rahnavard A, McIver LJ, Ma S, Zhang Y, Nguyen LH, Tickle TL, Weingart G, Ren B, Schwager EHet al, Multivariable Association Discovery in Population-scale Meta-omics Studies. PLoS computational biology. 2021;17(11): e1009442.https://doi.org/10.1371/journal.pcbi.1009442.
   Web of Science ®Google Scholar
• Vinod HD. Generalized correlation and kernel causality with applications in development economics. Commun Stat - Simul Comput. 2017;46(6):4513–4534. doi:10.1080/03610918.2015.1122048.
   Web of Science ®Google Scholar
• McKeown NM, Meigs JB, Liu S, Saltzman E, Wilson PWF, Jacques PF. Carbohydrate nutrition, insulin resistance, and the prevalence of the metabolic syndrome in the Framingham offspring cohort. Diabetes Care. 2004;27(2):538–546. doi:10.2337/diacare.27.2.538.
   PubMed Web of Science ®Google Scholar
• Nanri A, Mizoue T, Noda M, Takahashi Y, Kato M, Inoue M, Tsugane S, Japan Public Health Center-based Prospective Study Group. Rice intake and type 2 diabetes in Japanese men and women: the Japan Public Health Center–based Prospective Study. Am J Clin Nutr. 2010;92(6):1468–1477. doi:10.3945/ajcn.2010.29512.
   PubMed Web of Science ®Google Scholar
• Tajima R, Kimura T, Enomoto A, Yanoshita K, Saito A, Kobayashi S, Masuda K, Lida K. Association between rice, bread, and noodle intake and the prevalence of non-alcoholic fatty liver disease in Japanese middle-aged men and women. Clin Nutr. 2017;36(6):1601–1608. doi:10.1016/j.clnu.2016.09.034.
   PubMed Web of Science ®Google Scholar
• Farese Robert V, Zechner R, Newgard Christopher B, Walther Tobias C. The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance. Cell Metab. 2012;15(5):570–573. doi:10.1016/j.cmet.2012.03.004.
   PubMed Web of Science ®Google Scholar
• Adams LA, Lymp JF, St. Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–121. doi:10.1053/j.gastro.2005.04.014.
   PubMed Web of Science ®Google Scholar
• Finck BN. Targeting Metabolism, Insulin Resistance, and Diabetes to Treat Nonalcoholic Steatohepatitis. Diabetes. 2018;67(12):2485–2493. doi:10.2337/dbi18-0024.
   PubMed Web of Science ®Google Scholar
• Anhê FF, Jensen BAH, Varin TV, Servant F, Van Blerk S, Richard D, Marceau S, Surette M, Biertho L, Lelouvier B, et al. Type 2 diabetes influences bacterial tissue compartmentalisation in human obesity. Nat Metab. 2020;2(3):233–242. doi:10.1038/s42255-020-0178-9.
   PubMedGoogle Scholar
• Fei N, Bruneau A, Zhang X, Wang R, Wang J, Rabot S, Gérard P, Zhao L. Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease. mBio. 2020;11(1):e03263–19. doi:10.1128/mBio.03263-19.
   PubMed Web of Science ®Google Scholar
• Zhu L, Baker SS, Gill C, Liu W, Alkhouri R, Baker RD, Gill SR. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology. 2013;57(2):601–609. doi:10.1002/hep.26093.
   PubMed Web of Science ®Google Scholar
• Osbelt L, Wende M, Almasi E, Derksen E, Muthukumarasamy U, Lesker TR, Galvez EJC, Pils MC, Schalk E, Chhatwal P, et al. Klebsiella oxytoca causes colonization resistance against multidrug-resistant K. pneumoniae in the gut via cooperative carbohydrate competition. Cell Host Microbe. 2021;29(11):1663–+. doi:10.1016/j.chom.2021.09.003.
   PubMed Web of Science ®Google Scholar
• Astbury S, Atallah E, Vijay A, Aithal GP, Grove JI, Valdes AM. Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis. Gut Microbes. 2020;11(3):569–580. doi:10.1080/19490976.2019.1681861.
   PubMed Web of Science ®Google Scholar
• Goffredo M, Mass K, Parks EJ, Wagner DA, McClure EA, Graf J, Savoye M, Pierpont B, Cline G, Santoro N, et al. Role of gut microbiota and short chain fatty acids in modulating energy harvest and fat partitioning in youth. J Clin Endocrinol Metab. 2016;101(11):4367–4376. doi:10.1210/jc.2016-1797.
   PubMed Web of Science ®Google Scholar
• Munukka E, Pekkala S, Wiklund P, Rasool O, Borra R, Kong L, Ojanen X, Cheng SM, Roos C, Tuomela S, et al. Gut-adipose tissue axis in hepatic fat accumulation in humans. J Hepatol. 2014;61(1):132–138. doi:10.1016/j.jhep.2014.02.020.
   PubMed Web of Science ®Google Scholar
• Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, et al. Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013;11(7):868–75 e1–3. doi:10.1016/j.cgh.2013.02.015.
   Web of Science ®Google Scholar
• Bommer Guido T, MacDougald Ormond A. Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a Locus. Cell Metab. 2011;13(3):241–247. doi:10.1016/j.cmet.2011.02.004.
   PubMed Web of Science ®Google Scholar
• Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125–1131. doi:10.1172/JCI0215593.
   PubMed Web of Science ®Google Scholar
• Caballero F, Fernández A, De Lacy AM, Fernández-Checa JC, Caballería J, García-Ruiz C. Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J Hepatol. 2009;50(4):789–796. doi:10.1016/j.jhep.2008.12.016.
   PubMed Web of Science ®Google Scholar
• Purushotham A, Schug TT, Xu Q, Surapureddi S, Guo X, Li X. Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation. Cell Metab. 2009;9(4):327–338. doi:10.1016/j.cmet.2009.02.006.
   PubMed Web of Science ®Google Scholar
• Collin de L’hortet A, Takeishi K, Guzman-Lepe J, Morita K, Achreja A, Popovic B, Wang Y, Handa K, Mittal A, Meurs N, et al. Generation of human fatty livers using custom-engineered induced pluripotent stem cells with modifiable SIRT1 metabolism. Cell Metab. 2019;30(2):385–401.e9. doi:10.1016/j.cmet.2019.06.017.
   PubMed Web of Science ®Google Scholar
• Erion DM, Yonemitsu S, Nie Y, Nagai Y, Gillum MP, Hsiao JJ, Iwasaki T, Stark R, Weismann D, Yu XX. SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats. 2009; 106:11288–11293.
   Google Scholar
• Yoon M-S. The role of mammalian target of rapamycin (mTOR) in insulin signaling. Nutrients. 2017;9(11):1176. doi:10.3390/nu9111176.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–293. doi:10.1016/j.cell.2012.03.017.
   PubMed Web of Science ®Google Scholar
• Polak P, Cybulski N, Feige JN, Auwerx J, Rüegg MA, Hall MN. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 2008;8(5):399–410. doi:10.1016/j.cmet.2008.09.003.
   PubMed Web of Science ®Google Scholar
• Khamzina L, Veilleux A, Bergeron S, Marette A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology. 2005;146(3):1473–1481. doi:10.1210/en.2004-0921.
   PubMed Web of Science ®Google Scholar
• Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature. 2004;431:200–205. doi:10.1038/nature02866.
   PubMed Web of Science ®Google Scholar
• Okuno T, Kakehashi A, Ishii N, Fujioka M, Gi M, Wanibuchi H. mTOR activation in liver tumors is associated with metabolic syndrome and non-alcoholic steatohepatitis in both mouse models and humans. Cancers (Basel). 2018;10(12):465. doi:10.3390/cancers10120465.
   PubMed Web of Science ®Google Scholar
• Wallace TM, Utzschneider KM, Tong J, Carr DB, Zraika S, Bankson DD, Knopp RH, Kahn SE. Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat. Diabetes Care. 2007;30(10):2673–2678. doi:10.2337/dc06-1758.
   PubMed Web of Science ®Google Scholar
• Kindt A, Liebisch G, Clavel T, Haller D, Hörmannsperger G, Yoon H, Kolmeder D, Sigruener A, Krautbauer S, Seeliger C, et al. The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice. Nat Commun. 2018;9(1):3760. doi:10.1038/s41467-018-05767-4.
   PubMed Web of Science ®Google Scholar
• Wellman AS, Metukuri MR, Kazgan N, Xu X, Xu Q, Ren NSX, Czopik A, Shanahan MT, Kang A, Chen W, et al. Intestinal epithelial sirtuin 1 regulates intestinal inflammation during aging in mice by altering the intestinal microbiota. Gastroenterology. 2017;153:772–786. doi:10.1053/j.gastro.2017.05.022.
   PubMed Web of Science ®Google Scholar
• Trosvik P, de Muinck Ej, Stenseth NC, de Muinck EJ. Biotic interactions and temporal dynamics of the human gastrointestinal microbiota. Isme J. 2015;9(3):533–541. doi:10.1038/ismej.2014.147.
   PubMed Web of Science ®Google Scholar
• Chung GE, Youn J, Kim YS, Lee JE, Yang SY, Lim JH, Song JH, Doo EY, Kim JS. Dietary patterns are associated with the prevalence of nonalcoholic fatty liver disease in Korean adults. Nutrition. 2019;62:32–38. doi:10.1016/j.nut.2018.11.021.
   PubMed Web of Science ®Google Scholar
• Fan JG, Kim SU, Wong VW. New trends on obesity and NAFLD in Asia. J Hepatol. 2017;67(4):862–873. doi:10.1016/j.jhep.2017.06.003.
   PubMed Web of Science ®Google Scholar
• Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Oren R. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol. 2007;47(5):711–717. doi:10.1016/j.jhep.2007.06.020.
   PubMed Web of Science ®Google Scholar
• Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Fagà E, Silli B, Pagano G. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003;37(4):909–916. doi:10.1053/jhep.2003.50132.
   PubMed Web of Science ®Google Scholar
• Koo BK, Joo SK, Kim D, Bae JM, Park JH, Kim JH, Kim W. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2018;33(6):1277–1285. doi:10.1111/jgh.14056.
   PubMed Web of Science ®Google Scholar
• Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, Lee KL, Kim W. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol. 2017;66(1):123–131. doi:10.1016/j.jhep.2016.08.019.
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu Y-C, Torbenson MS, Unalp-Arida A, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–1321. doi:10.1002/hep.20701.
   PubMed Web of Science ®Google Scholar
• Brunt EM, Kleiner DE, Wilson LA, Belt P, Neuschwander-Tetri BA, Network NCR, Network NCR. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatol. 2011;53(3):810–820. doi:10.1002/hep.24127.
   PubMed Web of Science ®Google Scholar
• Ahn Y, Kwon E, Shim JE, Park MK, Joo Y, Kimm K, Park C, Kim DH. Validation and reproducibility of food frequency questionnaire for Korean genome epidemiologic study. Eur J Clin Nutr. 2007;61(12):1435–1441. doi:10.1038/sj.ejcn.1602657.
   PubMed Web of Science ®Google Scholar
• Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes. 2003;52(10):2461–2474. doi:10.2337/diabetes.52.10.2461.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi:10.1007/BF00280883.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 2010;7(5):335–336. doi:10.1038/nmeth.f.303.
   PubMed Web of Science ®Google Scholar
• DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, Huber T, Dalevi D, Hu P, Andersen GL, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72(7):5069–5072. doi:10.1128/AEM.03006-05.
   PubMed Web of Science ®Google Scholar
• Caporaso JG, Bittinger K, Bushman FD, DeSantis TZ, Andersen GL, Knight R. PyNAST: a flexible tool for aligning sequences to a template alignment. Bioinformatics. 2010;26(2):266–267. doi:10.1093/bioinformatics/btp636.
   PubMed Web of Science ®Google Scholar
• Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, Brown CT, Porras-Alfaro A, Kuske CR, Tiedje JM, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014;42:D633–D42. doi:10.1093/nar/gkt1244.
   PubMed Web of Science ®Google Scholar
• Haas BJ, Gevers D, Earl AM, Feldgarden M, Ward DV, Giannoukos G, Ciulla D, Tabbaa D, Highlander SK, Sodergren E, et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011;21(3):494–504. doi:10.1101/gr.112730.110.
   PubMed Web of Science ®Google Scholar
• Sung J, Cho S-I, Lee K, Ha M, Choi E-Y, Choi J-S, Kim H, Kim J, Hong KS, Kim Y, et al. Healthy Twin: a twin-family study of Korea—protocols and current status. Twin Res Hum Genet. 2006;9(6):844–848. doi:10.1375/twin.9.6.844.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim D, Kim HJ, Lee CH, Yang JI, Kim W, Kim YJ, Yoon J-H, Cho S-H, Sung M-W, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503–508. doi:10.1016/j.dld.2009.08.002.
   PubMedGoogle Scholar
• Lim MY, You HJ, Yoon HS, Kwon B, Lee JY, Lee S, Song Y-M, Lee K, Sung J, Ko G, et al. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome. Gut. 2017;66(6):1031–1038. doi:10.1136/gutjnl-2015-311326.
   PubMed Web of Science ®Google Scholar
• Koo BK, Joo SK, Kim D, Lee S, Bae JM, Park JH, Kim JH, Chang MS, Kim W . Development and validation of a scoring system, based on genetic and clinical factors, to determine risk of steatohepatitis in asian patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18(11):2592–9.e10. doi:10.1016/j.cgh.2020.02.011.
   PubMed Web of Science ®Google Scholar
• Grimaudo S, Pipitone RM, Pennisi G, Celsa C, Cammà C, Di Marco V, Barcellona MR, Boemi R, Enea M, Giannetti A, et al. Association Between PNPLA3 rs738409 C>G Variant and Liver-related outcomes in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2020;18(4):935–44.e3. doi:10.1016/j.cgh.2019.08.011.
   PubMed Web of Science ®Google Scholar
• Liu Y-L, Reeves HL, Burt AD, Tiniakos D, McPherson S, Leathart JBS, Allison MED, Alexander GJ, Piguet A-C, Anty R, et al. TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease. Nat Commun. 2014;5(1):4309. doi:10.1038/ncomms5309.
   PubMed Web of Science ®Google Scholar
• Donati B, Dongiovanni P, Romeo S, Meroni M, McCain M, Miele L, Petta S, Maier S, Rosso C, De Luca L, et al. MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals. Sci Rep. 2017;7(1):4492. doi:10.1038/s41598-017-04991-0.
   PubMed Web of Science ®Google Scholar
• Pirola CJ, Garaycoechea M, Flichman D, Arrese M, San Martino J, Gazzi C, Casta&ntildeo GO, Sookoian SC. Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease[S]. J Lipid Res. 2019;60(1):176–185. doi:10.1194/jlr.P089953.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012;29(1):15–21. doi:10.1093/bioinformatics/bts635.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics. 2015;31(2):166–169. doi:10.1093/bioinformatics/btu638.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Oksanen J, Blanchet FG, Kindt R, Legendre P, Minchin PR, O’Hara R, Simpson GL, Sólymos P, Stevens M, Wagner H. vegan: Community Ecology Package. 2012. Software http://CRAN.R-project.org/package=vegan
   Google Scholar
• Evans JS, Murphy MA, Holden ZA, Cushman SA. Modeling species distribution and change using random forest. Predictive species and habitat modeling in landscape ecology. New York: Springer; 2011. p. 139–159.
   Google Scholar
• Douglas GM, Maffei VJ, Zaneveld JR, Yurgel SN, Brown JR, Taylor CM, Huttenhower C, Langille M. PICRUSt2 for prediction of metagenome functions. Nat Biotechnol. 2020;38(6):685–688. doi:10.1038/s41587-020-0548-6.
   PubMed Web of Science ®Google Scholar
• Boekel J, Chilton JM, Cooke IR, Horvatovich PL, Jagtap PD, Käll L, Lehtiö J, Lukasse P, Moerland PD, Griffin TJ, et al. Multi-omic data analysis using Galaxy. Nat Biotechnol. 2015;33(2):137–139. doi:10.1038/nbt.3134.
   PubMed Web of Science ®Google Scholar
• Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, Müller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12(1):77. doi:10.1186/1471-2105-12-77.
   PubMed Web of Science ®Google Scholar
• Vinod HD. Generalized correlation and kernel causality with applications in development economics. Commun Stat - Simul Comput. 2017;46:4513–4534.
   Web of Science ®Google Scholar
• Vinod HD. Generalized correlations and kernel causality using R package generalCorr. Available at SSRN 2782223 2016.
   Google Scholar
• Otasek D, Morris JH, Bouças J, Pico AR, Demchak B. Cytoscape Automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185. doi:10.1186/s13059-019-1758-4.
   PubMed Web of Science ®Google Scholar